Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-31.2%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 3.17% |
| 2024 | 5.97% |
| 2023 | 66.67% |
| 2022 | -90.22% |
| 2021 | 26.45% |
| 2020 | 20.63% |
| 2019 | -107.25% |
| 2018 | 0.00% |
| 2017 | 0.00% |